Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Edmonton Radiopharmaceutical Centre (ERC) is a specialized medical facility operated by Alberta Health Services (AHS) that focuses on the production, distribution, and development of radiopharmaceuticals. Based in Edmonton, Alberta, the center utilizes advanced cyclotron technology at the Cross Cancer Institute and the University of Alberta to manufacture a wide range of diagnostic and therapeutic isotopes. As a key component of the Radiopharmaceutical Services of Alberta (RSA) program, the ERC supplies over 20 imaging facilities across the province, supporting approximately 75,000 patients annually. Beyond routine production, the center is actively involved in clinical research, providing access to novel radiopharmaceuticals for oncology, neurology, and cardiology. Its capabilities include GMP-compliant fabrication, testing, and distribution of medical isotopes and essential cold kits.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Edmonton Radiopharmaceutical Centre.